John Schieszer, MA

Early intervention is essential to treating neuropathy in those with prediabetes.

Induced pluripotent stem cells offer a new way to study insulin resistance and other metabolic disorders in humans.

During the past 50 years, diabetes research and management has come a long way, although there is still work to be done.

Activity in certain brain regions of teenagers with type 1 diabetes was increased or decreased with hyperglycemia and hypoglycemia.

PE0139, a super long-acting basal insulin, and PB1023, a weekly GLP-1 receptor agonist, may lead to novel approach to treating diabetes.

Unsupervised closed loop insulin delivery is safe and feasible in the home setting in teens with type 1 diabetes.

Adding liraglutide to insulin in a closed loop system may reduce postprandial hyperglycemia as well as insulin requirements, compared with insulin monotherapy.

Children may have a higher risk for fat accumulation and insulin resistance if their mothers were obese.

Food insecurity has an impact on glycemic control and vegetable consumption in Latino patients with diabetes.

GLP-1 receptor agonist may be able to reduce glycemic variability rather than a prandial insulin.

Sitagliptin did not affect rates of cardiovascular complications or heart failure in high-risk patients with type 2 diabetes.

Lixisenatide has neutral effect on heart failure and other cardiovascular outcomes.

Achieving greater HbA1c reductions with fixed-ratio combination insulin glargine/lixisenatide did not increase rates of hypoglycemia.

Patients with type 2 diabetes and cardiovascular disease may benefit from long-term treatment with dapagliflozin.

Adding liraglutide to insulin degludec improved HbA1c and reduced risk for hypoglycemia, as compared with insulin glargine in type 2 diabetes.

Patients with type 2 diabetes who lost weight during 1 year of treatment with dapagliflozin appear to have maintained that weight loss after 4 years.

Results reveal a negative association between survival and acquisition of self-monitoring blood glucose supplies.

Timing of radioactive iodine ablation doesn’t affect overall survival in papillary thyroid cancer.

Because adrenal enlargement is more common in some patients, hormonal evaluation may be useful in determining its clinical relevance.

Sonographic pattern should be used to determine the threshold for thyroid nodule biopsy and can stratify the risk for malignancy.

Virtual case-based simulations may reinforce the importance of foot care for health care providers managing patients with diabetes.

Prescribing oral medications alone may effectively treat patients with type 2 diabetes and HbA1c levels exceeding 9%.

Obese women who undergo thyroidectomy may require a higher dose of levothyroxine than nonobese women.

The use of certified diabetes educator ambassadors may improve diabetes management while reducing the burden on the shortage of endocrinologists.

Bionic pancreas will offer viable alternative for patients with type 1 diabetes, according to data presented at AACE 2015.

Many patients with adrenal insufficiency do not receive adequate education on steroid dose adjustment or have emergency glucocorticoid kits.

New sonographic patterns proposed in the provisional 2014 ATA guidelines perform well for medullary thyroid cancer.

The benefits of testosterone therapy outweigh the risks, according to experts, and the FDA may need to rethink its stance.

The American Association of Clinical Endocrinologists has developed a new module and toolkit for obesity medicine.